全文获取类型
收费全文 | 6620篇 |
免费 | 378篇 |
国内免费 | 171篇 |
专业分类
耳鼻咽喉 | 53篇 |
儿科学 | 99篇 |
妇产科学 | 156篇 |
基础医学 | 429篇 |
口腔科学 | 307篇 |
临床医学 | 1838篇 |
内科学 | 622篇 |
皮肤病学 | 61篇 |
神经病学 | 338篇 |
特种医学 | 99篇 |
外科学 | 741篇 |
综合类 | 410篇 |
预防医学 | 823篇 |
眼科学 | 29篇 |
药学 | 444篇 |
4篇 | |
中国医学 | 366篇 |
肿瘤学 | 350篇 |
出版年
2024年 | 15篇 |
2023年 | 269篇 |
2022年 | 545篇 |
2021年 | 527篇 |
2020年 | 483篇 |
2019年 | 470篇 |
2018年 | 410篇 |
2017年 | 337篇 |
2016年 | 267篇 |
2015年 | 223篇 |
2014年 | 673篇 |
2013年 | 557篇 |
2012年 | 385篇 |
2011年 | 492篇 |
2010年 | 303篇 |
2009年 | 292篇 |
2008年 | 219篇 |
2007年 | 135篇 |
2006年 | 172篇 |
2005年 | 118篇 |
2004年 | 84篇 |
2003年 | 32篇 |
2002年 | 36篇 |
2001年 | 29篇 |
2000年 | 17篇 |
1999年 | 14篇 |
1998年 | 16篇 |
1997年 | 15篇 |
1996年 | 6篇 |
1995年 | 4篇 |
1994年 | 1篇 |
1993年 | 2篇 |
1992年 | 4篇 |
1990年 | 1篇 |
1988年 | 2篇 |
1987年 | 2篇 |
1985年 | 1篇 |
1983年 | 1篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1979年 | 1篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1974年 | 1篇 |
1973年 | 1篇 |
1971年 | 2篇 |
1970年 | 1篇 |
排序方式: 共有7169条查询结果,搜索用时 31 毫秒
171.
300例糖尿病患者社区强化管理和治疗的疗效观察 总被引:24,自引:0,他引:24
目的 探索糖尿病社区强化管理和治疗的有效模式 ,提高糖尿病患者的治疗达标率 ,减少医药费。 方法 选择已经确诊的糖尿病患者 30 0例 ,按照同等病情分为强化管理和治疗组及普通治疗组。强化管理和治疗组采用量化饮食治疗、量化运动治疗、指导合理用药、健康教育和心理疏导 ,医生对患者一对一地指导等治疗方法 ;普通治疗组为药物治疗和一般性教育。观察两组连续治疗 3个月病情控制与药费情况。 结果 强化管理和治疗组患者的空腹血糖值平均为 6 .48mm ol/ L,明显低于普通治疗组的 7.6 0 mm ol/ L(P<0 .0 0 1) ;餐后血糖值平均为 8.5 9mm ol/ L,明显低于普通治疗组的 11.31m mol/ L (P<0 .0 0 1)。患者的血糖达到控制良好标准者占 48.4% ,明显高于普通组 2 0 .8% (P<0 .0 0 1)。血糖控制仍在不良状态的患者强化组为 2 6 .1% ,明显低于普通组的 47.7% (P<0 .0 0 1)。强化管理和治疗组糖化血红蛋白 (Hb A1c)平均为 (7.79± 1.13) % ,明显低于普通治疗组 9.31(± 1.85 ) % (P<0 .0 0 1)。 Hb A1c控制良好率为 5 2 .3%明显高于普通组的 18.8% (P<.0 0 1)。 BMI、腰围、血脂两组无明显差别。糖尿病患者的医药费强化管理和治疗组每人每月下降 5 9.9元 ,下降幅度为2 3.6 %。普通治疗组每人每月上涨 1.8元 ,上 相似文献
172.
《Research in social & administrative pharmacy》2020,16(7):854-874
BackgroundDespite the availability of evidence-based guidance to deliver effective diabetes care, many patients do not achieve goals as recommendations. This systematic review was to synthesize useful insight perspectives by patients and providers to identify factors related to diabetes management using Chronic Care Model.ObjectiveThis systematic review aimed to synthesize perspectives by patients and providers in order to identify factors related to diabetes management.MethodsDatabases were searched including CINAHL, PubMed, Science Direct, and Web of Science from January 2001 to September 2017. Combination of search terms were used like ‘qualitative,’ ‘diabetes management,’ ‘patients’ perspective,’ and ‘provider's perspective.’ All qualitative studies used were in English with available full text. Chronic Care Model framework was used to analyze the content and to organize the findings.ResultsOf 108 articles used, only 23 of this met the inclusion criteria. Nine factors were identified including community linkage, health service system for diabetic patients, continuity of care, self-management, providers' support, referral system, patient-provider interaction, increasing competency of healthcare providers and family support. Community linkage was revealed to be an important factor to encourage diabetic patients to look after their disease while health service system showed the limit of accessibility due to location, medical service availability, finance, information, and time. Continuity of care has shown lack of coordination in referral system within a health care team and self-management was dependent on the knowledge, beliefs, attitude, and behavior of the patient. More so, providers’ support through an effective plan and/or strategy has also indicated to help patients get their target goal. Poor interaction between patients and health providers was found to be largely attributed to language barrier and lack of communication skill. Improving competency for the health providers can be achieved through continuing professional education. Both perspectives supported a family involvement and community resources for diabetes patients.ConclusionFactors related to diabetes management from nine themes showed various gaps in both perspectives. Further research on new models for diabetes management is required. 相似文献
173.
ObjectiveTo systematically evaluate the acceptability of high-technology augmentative and alternative communication (high-tech AAC) among ICU patients who are voiceless guided by the technology acceptance model (TAM).MethodsWe searched the Cochrane Library, EMBASE, PubMed, CINAHL, PsycINFO, Web of Science, SinoMed, China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database and Wanfang Database from database inception to September 2019. Studies that examined conscious nonverbal ICU patients with high-tech AAC intervention were included. Two reviewers independently collected and evaluated all the studies. The methodological quality was assessed by using the Joanna Briggs Institute critical appraisal tool.ResultsEighteen studies with a total of 914 patients met the inclusion criteria, and the quality of the studies varied from low to moderate. Based on the TAM, ICU voiceless patients perceived that high-tech AAC was useful, was easy to use, decreased communication difficulties, reduced negative emotions, and improved symptom identification and management. Patients maintained a positive attitude and were willing to continue to use high-tech AAC.ConclusionsAlthough the existing evidence is limited, voiceless patients regard high-tech AAC devices as a useful, reliable, and acceptable alternative communication choice in the ICU. Multicenter, large-sample, and high-quality studies are highly recommended in the future. 相似文献
174.
ObjectivesThe aim of this study was to critically appraise and evaluate effects of low- and high-dose curcuminoids on pain and functional improvement in patients with knee osteoarthritis (OA) and to compare adverse events (AEs) between curcuminoids and non-steroid anti-inflammatory drugs (NSAIDs).MethodsWe systematically reviewed all randomized controlled trials (RCTs) on curcuminoids in knee osteoarthritis from the PubMed, Embase, Cochrane Library, AMED, Cinahl, ISI Web of Science, Chinese medical database, and Indian Scientific databases from inception to June 21, 2021.ResultsWe included eleven studies with a total of 1258 participants with primary knee OA. The meta-analysis results showed that curcuminoids were significantly more effective than comparators regarding visual analogue scale (VAS) and Western Ontario and McMaster Universities Arthritis Index (WOMAC) pain scores. However, no significant difference in pain relief or AEs between the high-dose (daily dose ≥1000 mg or total dose ≥42 gm) and low-dose (daily dose <1000 mg or total dose <42 gm) curcuminoid treatments was observed. When comparing curcumininoids versus NSAIDs, a significant difference in VAS pain was found. For AE analysis, three of our included studies used NSAIDs as comparators, with all reporting higher AE rates in the NSAID group, though significance was reached in only one study.ConclusionsThe results of our meta-analysis suggest that low- and high-dose curcuminoids have similar pain relief effects and AEs in knee OA. Curcuminoids are also associated with better pain relief than NSAIDs; therefore, using curcuminoids as an adjunctive treatment in knee OA is recommended. 相似文献
175.
目的 系统评价肥胖症患者减重代谢术后的饮食体验的研究,全面了解其存在的饮食问题与管理需求,为更好地开展临床医疗工作提供依据。 方法 计算机检索Cochrane Library、乔安娜布里格斯研究所循证卫生保健中心数据库、PubMed、Embase、Web of Science、CINAHL、PsycINFO、中国知网、万方数据库、中国生物医学文献数据库。搜集有关肥胖症患者减重代谢术后饮食体验的质性研究,检索年限为建库至2021年1月。采用澳大利亚乔安娜布里格斯研究所循证卫生保健中心质性研究质量评价标准评价文献质量,采用汇集性整合的方法进行结果整合。 结果 共纳入18项研究,提炼39个结果,归纳为7个类别,综合为4个整合结果。①减重代谢术后患者进食状态的变化:饮食方式的变化、饮食管理阶段的变化;②减重代谢术后积极的进食策略;③减重代谢术后消极的进食体验和不良饮食行为:消极的进食体验、不良饮食行为及原因;④减重代谢术后患者寻求多方面的饮食管理支持:医护人员的饮食管理支持、家人和朋友的饮食管理支持、社会组织的饮食管理支持。 结论 医护人员应重视患者在减重代谢术后已出现的或可能会出现的饮食问题,根据相关原因,有针对性的提供支持与帮助以应对术后饮食挑战,指导患者建立正确的饮食行为,实现并维持最佳的减重效果,提高生活质量。 相似文献
176.
Fiona J. Charlson Alize J. Ferrari Abraham D. Flaxman Harvey A. Whiteford 《Journal of affective disorders》2013
Background
In order to capture the differences in burden between the subtypes of depression, the Global Burden of Disease 2010 Study for the first time estimated the burden of dysthymia and major depressive disorder separately from the previously used umbrella term ‘unipolar depression’. A global summary of epidemiological parameters are necessary inputs in burden of disease calculations for 21 world regions, males and females and for the year 1990, 2005 and 2010. This paper reports findings from a systematic review of global epidemiological data and the subsequent development of an internally consistent epidemiological model of dysthymia.Methods
A systematic search was conducted to identify data sources for the prevalence, incidence, remission and excess-mortality of dysthymia using Medline, PsycINFO and EMBASE electronic databases and grey literature. DisMod-MR, a Bayesian meta-regression tool, was used to check the epidemiological parameters for internal consistency and to predict estimates for world regions with no or few data.Results
The systematic review identified 38 studies meeting inclusion criteria which provided 147 data points for 30 countries in 13 of 21 world regions. Prevalence increases in the early ages, peaking at around 50 years. Females have higher prevalence of dysthymia than males. Global pooled prevalence remained constant across time points at 1.55% (95%CI 1.50–1.60). There was very little regional variation in prevalence estimates.Limitations
There were eight GBD world regions for which we found no data for which DisMod-MR had to impute estimates.Conclusion
The addition of internally consistent epidemiological estimates by world region, age, sex and year for dysthymia contributed to a more comprehensive estimate of mental health burden in GBD 2010. 相似文献177.
Mismatch negativity (MMN) is a promising window on how the functional integrity of auditory sensory memory and change discrimination is modulated by age and relevant clinical conditions. However, the effects of aging on MMN have remained somewhat elusive, particularly at short interstimulus intervals (ISIs). We performed a meta-analysis of peer-reviewed MMN studies that had targeted both young and elderly adults to estimate the mean effect size. Nine studies, consisting of 29 individual investigations, were included and the final total study population consisted of 182 young and 165 elderly subjects. The effects of different deviant types and duration of ISIs on the effect size were assessed. The overall mean effect size was 0.63 (95% CI at 0.43–0.82). The effect sizes for long ISI (> 2 s, effect size 0.68, 95% CI at 0.31–1.06) and short ISI (< 2 s, effect size 0.61, 95% CI at 0.39–0.84) were both considered moderate. A further analysis showed a prominent aging-related decrease in MMN responses to duration and frequency changes at short ISIs. It was also interesting to note that the effect size was about 25% larger for duration deviant condition compared to the frequency deviant condition. In conclusion, a reduced MMN response to duration and frequency deviants is a robust feature among the aged adults, which suggests that there has been a decline in the functional integrity of central auditory processing in this population. 相似文献
178.
179.
《Revue neurologique》2021,177(7):760-764
Regular and frequent use of analgesics and acute antimigraine drugs can increase the frequency of headache, and induce the transition from episodic to chronic migraine or medication-overuse headache (MOH). The one-year prevalence of this condition is between 1% and 2% in Europe, provoking substantial burden. MOH is more prevalent in people with comorbid depression, anxiety, and other chronic pain conditions. This paper aims at presenting an updating of French recommendations regarding treatments strategies. Prior French recommendations, published in 2014, were written in French. A literature search in the major medical databases including the terms “medication overuse headache”, “symptomatic medication overuse”, published between 2010 and 2020 was carried out. Three main strategies can be recommended and conducted in parallel: education and explanations about the negative consequences of overusing acute antimigraine drugs, discontinuation of the overused medication, and finally, preventive drug therapy and non-pharmacological prevention. Medication overuse headache remains a debated problem and evidence for the most effective treatment strategy is needed. 相似文献
180.
L.M. Sánchez-Gómez M. Polo-deSantos A. Pinel-González C. Oreja-Guevara S. Luengo-Matos 《Neurología (Barcelona, Spain)》2021,36(6):440-450
IntroductionThis study aimed to assess the safety and effectiveness of peripheral neurostimulation of the sphenopalatine ganglion (SPG) in the treatment of refractory chronic cluster headache.DevelopmentVarious medical databases were used to perform a systematic review of the scientific literature. The search for articles continued until 31 October 2016, and included clinical trials, systematic reviews and/or meta-analyses, health technology assessment reports, and clinical practice guidelines that included measurements of efficiency/effectiveness or adverse effects associated with the treatment. The review excluded cohort studies, case-control studies, case series, literature reviews, letters to the editor, opinion pieces, editorials, and studies that had been duplicated or outdated by later publications from the same institution. Regarding effectiveness, we found that SPG stimulation had positive results for pain relief, attack frequency, medication use, and patients’ quality of life. In the results regarding safety, we found a significant number of adverse events in the first 30 days following the intervention. Removal of the device was necessary in some patients. Little follow-up data, and no long-term data, is available.ConclusionsThese results are promising, despite the limited evidence available. We consider it essential for research to continue into the safety and efficacy of SPG stimulation for patients with refractory chronic cluster headache. In cases where this intervention may be indicated, treatment should be closely monitored. 相似文献